Login / Signup

High-dose dual therapy versus culture-based susceptibility-guided therapy as a rescue regimen for Helicobacter pylori infection: a randomized controlled trial.

Zhe ZhaoPei-Ying ZouNa-Yun SuYan GuoXing-Wei WangJing-Tao ZhaoHao MeiQing ShiBin WangDong-Feng ChenChun-Hui Lan
Published in: Therapeutic advances in gastroenterology (2022)
This clinical trial was registered at the Chinese Clinical Trail Registry (trail registration number: ChiCTR1900025044).
Keyphrases
  • helicobacter pylori infection
  • high dose
  • clinical trial
  • helicobacter pylori
  • randomized controlled trial
  • open label
  • bone marrow
  • phase ii
  • cell therapy
  • double blind
  • smoking cessation